Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of “Buy” from Analysts
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given an average recommendation of “Buy” by the ten ratings firms that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given an average recommendation of “Buy” by the ten ratings firms that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among […]
